Job Description

• To independently design, propose, develop and implement new approaches and innovative research projects to meet project and customer requirements.
• Identify new innovation opportunities for the expansion of Biology portfolio and technologies.
• Effectively manages their own time, able to work in a dynamic environment and balance multiple projects in parallel.
• To ensure maintenance of secure and accurate records of all project work and time spent working on allocated projects.
• Writes clear and concise reports for internal circulation and external publication.
• Independently evaluates, interprets, draws conclusions, and implements solutions.
• Actively expand knowledge on current and future projects and biology trends in the Drug Discovery industry
• To implement key software and IT design tools to process data and generate results.

Qualifications

At least 3 years’ experience in a multi-disciplinary research environment within the life science industry with relevant experience in cell-based assay development. Experience of cell imaging and / or mitochondrial cell biology would be an advantage.

CANDIDATE PROFILE :

You will also be able to demonstrate good understanding of biology / biochemistry sufficiently to interpret routine results, develop assays in line with customer requirements and use problem-solving skills to propose alternatives.

You are a key team player with the ability to deliver results within tight deadlines. You possess excellent inter-personal and communication skills, combined with a strong customer-focused approach. The ability to co-ordinate within interdisciplinary teams would be an asset. In return, Eurofins Integrated Discovery UK Ltd offers an excellent comprehensive total reward package.

Additional Information

HOW TO APPLY :

Are you the person we are looking for? If so, please visit our web-site at for more information on how to apply or send your CV and a covering letter to quoting job reference : EID / 13 / 0324 . The closing date for applications is Monday 8th July 2024 .